Skip to main content
BIOX
NASDAQ Industrial Applications And Services

Major Shareholder Sells $369K in Bioceres Crop Solutions Stock, Reducing Stake to 7.95%

Analysis by Wiseek AI
Sentiment info
Negative
Importance info
7
Price
$0.503
Mkt Cap
$31.823M
52W Low
$0.347
52W High
$5.175
Market data snapshot near publication time

Summary

Agriculture Investment Group Corp. and Granosur Holding Limited, significant shareholders in Bioceres Crop Solutions, reported selling 704,102 shares for approximately $369,364, decreasing their beneficial ownership to 7.95%.


Key Events

  • Significant Share Sale

    Agriculture Investment Group Corp. and Granosur Holding Limited sold an aggregate of 704,102 ordinary shares.

  • Total Proceeds from Sales

    The sales generated approximately $369,364 in gross proceeds from transactions occurring between March 23, 2026, and April 24, 2026.

  • Reduced Ownership Stake

    Following these sales, the reporting persons' beneficial ownership in Bioceres Crop Solutions Corp. decreased to 5,072,705 shares, representing 7.95% of the outstanding class.


Analysis

This Schedule 13D/A filing indicates a continued reduction in stake by a major institutional investor. The sale of over 700,000 shares, valued at nearly $370,000, represents a notable disposition for a company of Bioceres Crop Solutions' market capitalization. While not a complete exit, this ongoing selling pressure from a significant shareholder could signal a lack of conviction or a portfolio rebalancing, potentially creating an overhang on the stock. Investors should monitor future filings for further changes in this investor's position.

At the time of this filing, BIOX was trading at $0.50 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $31.8M. The 52-week trading range was $0.35 to $5.18. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BIOX - Latest Insights

BIOX
Jun 01, 2026, 5:16 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $0.4837
Real-time Price: $0.420 info
Change: -$0.0637 (-13%) info
Market Cap: $26.556M info
BIOX
Jun 01, 2026, 10:16 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $0.4338
Real-time Price: $0.420 info
Change: -$0.0138 (-3%) info
Market Cap: $26.556M info
BIOX
May 12, 2026, 4:01 PM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $0.451
Real-time Price: $0.420 info
Change: -$0.031 (-7%) info
Market Cap: $26.556M info
BIOX
May 11, 2026, 5:00 PM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $0.557789
Real-time Price: $0.420 info
Change: -$0.137789 (-25%) info
Market Cap: $26.556M info
BIOX
Apr 28, 2026, 11:23 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $0.4862
Real-time Price: $0.420 info
Change: -$0.0662 (-14%) info
Market Cap: $26.556M info
BIOX
Apr 28, 2026, 11:11 AM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $0.5033
Real-time Price: $0.420 info
Change: -$0.0833 (-17%) info
Market Cap: $26.556M info
BIOX
Mar 24, 2026, 4:05 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $0.4097
Real-time Price: $0.420 info
Change: +$0.0103 (+3%) info
Market Cap: $26.556M info
BIOX
Mar 17, 2026, 9:16 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $0.4365
Real-time Price: $0.420 info
Change: -$0.0165 (-4%) info
Market Cap: $26.556M info
BIOX
Mar 13, 2026, 5:23 PM EDT
Filing Type: 6-K
Importance Score:
10
Price at Filing: $0.530
Real-time Price: $0.420 info
Change: -$0.110 (-21%) info
Market Cap: $26.556M info
BIOX
Mar 13, 2026, 4:15 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $0.5277
Real-time Price: $0.420 info
Change: -$0.1077 (-20%) info
Market Cap: $26.556M info